Could an alcoholism drug help slow ALS? new trial launches
NCT ID NCT07204977
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 36 times
Summary
This early-stage study tests a drug called acamprosate in 30 adults with ALS who have a specific gene mutation (C9orf72). The main goal is to see if the drug is safe. Researchers will also check if it helps slow the disease by measuring changes in muscle function and daily living over 24 weeks. Participants take the drug as a pill three times a day and have regular clinic and phone visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.